Singapore, March 12 -- Precision for Medicine, a global leader in biomarker-driven clinical research and development, has announced the opening of its new Japan office, deepening its commitment to the Asia-Pacific region and reinforcing its role as a bridge between local expertise and global development execution.

Japan is the third-largest pharmaceutical market globally and maintains specific expectations for locally derived clinical data in pivotal trials. This requirement has historically created challenges for sponsors incorporating Japan into their development plans.

Precision's Tokyo office and senior leadership embedded in Japan will ensure high quality delivery and consistent global governance while empowering local staff to nav...